- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有13家主力机构披露2025-06-30报告期持股数据，持仓量总计739.04万股，占流通A股3.28%
- 波段诊断：
-
技术面诊股
诊断结果：5.5技术面打败了52%的股票
技术面评分前10的股票
近期的平均成本为10.46元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为10.46元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"10.46","date":1765095195,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2025.12.08","stock":"1.64","trade":"0.25","ind":"1.39"},{"date":"2025.12.05","stock":"-0.10","trade":"0.10","ind":"1.08"},{"date":"2025.12.04","stock":"-0.48","trade":"-0.40","ind":"0.40"},{"date":"2025.12.03","stock":"-0.57","trade":"-0.45","ind":"-0.78"},{"date":"2025.12.02","stock":"-1.23","trade":"-1.08","ind":"-0.68"},{"date":"2025.12.01","stock":"0.09","trade":"0.07","ind":"1.25"},{"date":"2025.11.28","stock":"0.38","trade":"-0.17","ind":"0.85"},{"date":"2025.11.27","stock":"0.00","trade":"-0.20","ind":"-0.25"},{"date":"2025.11.26","stock":"-0.09","trade":"1.10","ind":"1.02"},{"date":"2025.11.25","stock":"1.54","trade":"2.23","ind":"1.53"},{"date":"2025.11.24","stock":"3.18","trade":"1.45","ind":"0.37"},{"date":"2025.11.21","stock":"-5.62","trade":"-3.83","ind":"-3.41"},{"date":"2025.11.20","stock":"-2.20","trade":"-0.26","ind":"-0.76"},{"date":"2025.11.19","stock":"-3.19","trade":"-1.93","ind":"-0.00"},{"date":"2025.11.18","stock":"-0.88","trade":"-1.16","ind":"-0.92"},{"date":"2025.11.17","stock":"-1.22","trade":"-1.58","ind":"-0.11"},{"date":"2025.11.14","stock":"1.59","trade":"0.97","ind":"-1.93"},{"date":"2025.11.13","stock":"2.16","trade":"1.58","ind":"1.78"},{"date":"2025.11.12","stock":"1.74","trade":"0.46","ind":"-0.36"},{"date":"2025.11.11","stock":"0.18","trade":"0.64","ind":"-1.03"},{"date":"2025.11.10","stock":"1.49","trade":"1.26","ind":"0.18"}]
仟源医药,深证成指,化学制药指数
压力支撑
该股压力位为10.41元，支撑位为10.32元。
[{"text":"\u538b\u529b\u4f4d","value":"10.41","date":1765123200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"10.32","date":1765123200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.7资金面打败了49%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月08日 20:30
| 机构今日流向(万元) | -1144.10 | 机构5日流向(万元) | -4896.33 |
| 机构10日流向(万元) | -7347.12 | 机构20日流向(万元) | -17308.33 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加77.67万股，其中基金净减仓1家，主力净减仓11家，暂未发现中长期投资价值。
截止2025-06-30，共13家主力机构（基金10家，一般法人2家，QFII1家），持仓量总计739.04万股，占流通A股3.28%
其中，基金持仓与2024-12-31相比：
增仓：3家 ，增持 2.69万股
减仓：4家 ，减持 32.45万股
新出现在主力名单中：3家 ，持有152.1万股
从主力名单中消失：14家 ，原持有44.67万股
其中，基金持仓与2024-12-31相比：
增仓：3家 ，增持 2.69万股
减仓：4家 ，减持 32.45万股
新出现在主力名单中：3家 ，持有152.1万股
从主力名单中消失：14家 ，原持有44.67万股
消息面诊股
诊断结果：5.5消息面打败了31%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 仟源医药：公司治疗呼吸系统疾病药物和治疗感冒药物，
2025-11-26 - 仟源医药今日大宗交易折价成交300万股，成交额24
2025-11-25 - 仟源医药(11月25日)出现1笔大宗交易
2025-11-25 - 仟源医药今日大宗交易折价成交96.71万股，成交额
2025-11-21 - 仟源医药(11月21日)出现1笔大宗交易
2025-11-21 - 仟源医药今日大宗交易折价成交100万股，成交额90
2025-11-19 - 仟源医药(11月19日)出现1笔大宗交易
2025-11-19 - 概念动态|仟源医药新增“流感”概念
2025-11-13 - 仟源医药：公司有治疗呼吸系统药物盐酸氨溴索分散片和
2025-11-12 - 股东追踪|徐小安等新进仟源医药前十大流通股东
2025-10-30
消息列表
| 一般消息 | 募资投向 | 2025-09-18 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-26 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-09 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-08-07 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-06-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-15 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-01-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 1条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.3行业面打败了77%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.12.08","price":"1.39","value":"0.25"},{"date":"2025.12.05","price":"1.08","value":"0.10"},{"date":"2025.12.04","price":"0.40","value":"-0.40"},{"date":"2025.12.03","price":"-0.78","value":"-0.45"},{"date":"2025.12.02","price":"-0.68","value":"-1.08"},{"date":"2025.12.01","price":"1.25","value":"0.07"},{"date":"2025.11.28","price":"0.85","value":"-0.17"},{"date":"2025.11.27","price":"-0.25","value":"-0.20"},{"date":"2025.11.26","price":"1.02","value":"1.10"},{"date":"2025.11.25","price":"1.53","value":"2.23"},{"date":"2025.11.24","price":"0.37","value":"1.45"},{"date":"2025.11.21","price":"-3.41","value":"-3.83"},{"date":"2025.11.20","price":"-0.76","value":"-0.26"},{"date":"2025.11.19","price":"-0.00","value":"-1.93"},{"date":"2025.11.18","price":"-0.92","value":"-1.16"},{"date":"2025.11.17","price":"-0.11","value":"-1.58"},{"date":"2025.11.14","price":"-1.93","value":"0.97"},{"date":"2025.11.13","price":"1.78","value":"1.58"},{"date":"2025.11.12","price":"-0.36","value":"0.46"},{"date":"2025.11.11","price":"-1.03","value":"0.64"},{"date":"2025.11.10","price":"0.18","value":"1.26"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 海南海药 | 33.39% | 6.41% | 6.0分 |
| 2 | 康芝药业 | 29.93% | -3.70% | 4.9分 |
| 3 | *ST苏吴 | 29.17% | 27.84% | 5.8分 |
| 4 | 前沿生物 | 28.24% | -2.46% | 5.4分 |
| 5 | 常山药业 | 22.18% | -3.84% | 5.4分 |
| 6 | 海思科 | 15.04% | 3.27% | 6.1分 |
| 8 | 福元医药 | 12.74% | -1.03% | 6.4分 |
| 10 | 益方生物 | 11.95% | 7.39% | 6.2分 |
| 12 | 北大医药 | 10.19% | -0.83% | 5.9分 |
| 14 | 泽璟制药 | 9.62% | -0.06% | 5.9分 |
| 16 | *ST景峰 | 6.31% | -12.97% | 4.4分 |
| 18 | 民生健康 | 5.09% | -5.26% | 4.4分 |
| 20 | 普洛药业 | 4.73% | -0.12% | 6.0分 |
| 22 | 圣诺生物 | 4.11% | 2.45% | 6.1分 |
| 24 | 迪哲医药 | 3.27% | -0.75% | 4.2分 |
| 26 | 百利天恒 | 2.49% | -3.50% | 4.1分 |
| 28 | 信立泰 | 1.59% | -0.61% | 5.3分 |
| 30 | 必贝特 | 1.47% | -7.97% | 5.8分 |
| 32 | 哈三联 | 1.11% | 1.18% | 4.6分 |
| 34 | 华仁药业 | 0.85% | 1.71% | 6.0分 |
| 36 | 健康元 | 0.80% | 0.72% | 5.9分 |
| 38 | 山河药辅 | 0.50% | -2.70% | 4.2分 |
| 40 | 卫信康 | 0.27% | -0.97% | 5.7分 |
| 42 | 西点药业 | 0.10% | 3.10% | 5.2分 |
| 44 | ST复华 | 0.00% | -0.52% | 4.7分 |
| 46 | 百济神州 | -0.24% | -2.95% | 4.3分 |
| 48 | 尔康制药 | -0.52% | -1.80% | 4.5分 |
| 50 | 苑东生物 | -0.56% | 2.54% | 6.6分 |
| 52 | 哈药股份 | -0.80% | 2.49% | 5.6分 |
| 54 | 兴齐眼药 | -0.99% | 0.56% | 5.2分 |
| 56 | 双鹭药业 | -1.41% | -1.91% | 5.4分 |
| 58 | 海翔药业 | -1.57% | 0.80% | 5.0分 |
| 60 | 丰原药业 | -1.88% | 0.74% | 5.7分 |
| 62 | 天宇股份 | -2.13% | -1.71% | 4.5分 |
| 64 | 泰恩康 | -2.60% | -0.99% | 3.9分 |
| 66 | 拓新药业 | -2.90% | -5.59% | 4.4分 |
| 68 | 海森药业 | -3.11% | -0.79% | 4.8分 |
| 70 | 金石亚药 | -3.18% | -8.76% | 4.3分 |
| 72 | 赛托生物 | -3.25% | -2.17% | 3.9分 |
| 74 | 天新药业 | -3.39% | 1.04% | 5.1分 |
| 76 | 汉商集团 | -3.47% | -1.52% | 5.4分 |
| 78 | 华海药业 | -3.60% | -1.05% | 5.6分 |
| 80 | 华邦健康 | -3.76% | 0.83% | 5.3分 |
| 82 | 河化股份 | -3.81% | -3.93% | 4.4分 |
| 84 | 亿帆医药 | -3.96% | 2.77% | 5.3分 |
| 86 | 博瑞医药 | -4.20% | -2.40% | 5.0分 |
| 88 | 艾力斯 | -4.34% | -1.57% | 4.8分 |
| 90 | 奥翔药业 | -4.63% | -2.22% | 4.4分 |
| 92 | 丽珠集团 | -4.74% | -0.69% | 5.1分 |
| 94 | 华润双鹤 | -4.87% | -0.43% | 5.1分 |
| 96 | 海正药业 | -5.22% | 0.96% | 5.7分 |
| 98 | 誉衡药业 | -5.26% | -0.31% | 5.6分 |
| 100 | 北陆药业 | -5.52% | -0.85% | 4.7分 |
| 102 | 本立科技 | -5.61% | -1.37% | 4.8分 |
| 104 | - | -5.65% | -0.06% | 分 |
| 106 | 微芯生物 | -6.04% | 1.29% | 5.6分 |
| 108 | 诚意药业 | -6.15% | -1.35% | 5.5分 |
| 110 | 复旦张江 | -6.29% | -1.16% | 4.4分 |
| 112 | 浙江医药 | -6.56% | -1.06% | 4.9分 |
| 114 | 新天地 | -6.61% | -2.23% | 4.6分 |
| 116 | 美诺华 | -6.74% | 1.94% | 5.7分 |
| 118 | 健友股份 | -6.80% | -1.34% | 4.3分 |
| 120 | 力生制药 | -7.05% | -1.49% | 5.0分 |
| 122 | - | -7.41% | -3.00% | 分 |
| 124 | 鲁抗医药 | -8.17% | -2.33% | 5.0分 |
| 126 | 南新制药 | -8.22% | -4.96% | 4.2分 |
| 128 | 共同药业 | -8.51% | -2.07% | 4.4分 |
| 130 | 易明医药 | -8.75% | -0.27% | 4.5分 |
| 132 | - | -9.25% | -1.65% | 分 |
| 134 | - | -9.32% | -1.68% | 分 |
| 136 | 永安药业 | -9.44% | -2.89% | 4.2分 |
| 138 | - | -9.46% | -3.13% | 分 |
| 140 | 亚太药业 | -9.71% | -0.79% | 4.5分 |
| 142 | 人福医药 | -10.15% | -4.78% | 4.3分 |
| 144 | 德展健康 | -10.34% | -2.92% | 3.4分 |
| 146 | 科源制药 | -11.46% | 0.32% | 3.7分 |
| 148 | 千红制药 | -11.66% | -2.64% | 3.8分 |
| 150 | 上海谊众 | -12.05% | -5.19% | 4.5分 |
| 152 | - | -12.99% | -2.93% | 分 |
| 154 | 宏源药业 | -13.76% | -3.97% | 3.8分 |
| 156 | - | -14.97% | -4.16% | 分 |
| 158 | 舒泰神 | -23.74% | -7.10% | 3.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 43/219 ， 34/219。
[{"date":"2025-09-30","value":"7.01","vol":"1.46"},{"date":"2025-06-30","value":"0.13","vol":"1.21"},{"date":"2025-03-31","value":"3.45","vol":"-0.17"},{"date":"2024-12-31","value":"8.95","vol":"19.51"},{"date":"2024-09-30","value":"7.07","vol":"4.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.01 | 0.13 | 3.45 | 8.95 | 7.07 |
| 行业(%) | 1.46 | 1.21 | -0.17 | 19.51 | 4.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"67.72","vol":"49.47"},{"date":"2025-06-30","value":"68.84","vol":"49.43"},{"date":"2025-03-31","value":"69.51","vol":"49.23"},{"date":"2024-12-31","value":"66.91","vol":"50.77"},{"date":"2024-09-30","value":"66.99","vol":"50.51"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
67.72 | 68.84 | 69.51 | 66.91 | 66.99 |
| 行业(%) | 49.47 | 49.43 | 49.23 | 50.77 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 60/219 ， 114/219。
[{"date":"2025-09-30","value":"0.44","vol":"141.76"},{"date":"2025-06-30","value":"-7.01","vol":"78.53"},{"date":"2025-03-31","value":"-4.09","vol":"-0.84"},{"date":"2024-12-31","value":"5.92","vol":"17.76"},{"date":"2024-09-30","value":"6.45","vol":"45.69"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.44 | -7.01 | -4.09 | 5.92 | 6.45 |
| 行业(%) | 141.76 | 78.53 | -0.84 | 17.76 | 45.69 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-49.43","vol":"-5.21"},{"date":"2025-06-30","value":"-98.86","vol":"56.29"},{"date":"2025-03-31","value":"-43.17","vol":"-21.21"},{"date":"2024-12-31","value":"67.45","vol":"-20.55"},{"date":"2024-09-30","value":"422.48","vol":"-32.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-49.43 | -98.86 | -43.17 | 67.45 | 422.48 |
| 行业(%) | -5.21 | 56.29 | -21.21 | -20.55 | -32.33 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 40/219 ， 86/219。
[{"date":"2025-09-30","value":"0.39","vol":"0.31"},{"date":"2025-06-30","value":"0.25","vol":"0.21"},{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.57","vol":"0.43"},{"date":"2024-09-30","value":"0.41","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.39 | 0.25 | 0.12 | 0.57 | 0.41 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.47","vol":"1.95"},{"date":"2025-06-30","value":"0.82","vol":"1.31"},{"date":"2025-03-31","value":"0.40","vol":"0.67"},{"date":"2024-12-31","value":"2.21","vol":"3.22"},{"date":"2024-09-30","value":"1.69","vol":"2.18"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.47 | 0.82 | 0.40 | 2.21 | 1.69 |
| 行业(次) | 1.95 | 1.31 | 0.67 | 3.22 | 2.18 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"22.19","vol":"4.36"},{"date":"2025-06-30","value":"9.06","vol":"2.81"},{"date":"2025-03-31","value":"2.84","vol":"-28.76"},{"date":"2024-12-31","value":"3.31","vol":"-371.46"},{"date":"2024-09-30","value":"1.25","vol":"-9.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 22.19 | 9.06 | 2.84 | 3.31 | 1.25 |
| 行业 | 4.36 | 2.81 | -28.76 | -371.46 | -9.87 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.60","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.87","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.60 | - | 0.87 | - |
| 行业 | 0.00 | 1.72 | 0.00 | 1.99 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 83/219 ， 46/219。
[{"date":"2025-09-30","value":"0.92","vol":"3.49"},{"date":"2025-06-30","value":"0.94","vol":"3.67"},{"date":"2025-03-31","value":"0.96","vol":"3.59"},{"date":"2024-12-31","value":"0.88","vol":"3.34"},{"date":"2024-09-30","value":"0.84","vol":"3.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.92 | 0.94 | 0.96 | 0.88 | 0.84 |
| 行业 | 3.49 | 3.67 | 3.59 | 3.34 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.62","vol":"2.74"},{"date":"2025-06-30","value":"0.57","vol":"2.89"},{"date":"2025-03-31","value":"0.59","vol":"2.81"},{"date":"2024-12-31","value":"0.60","vol":"2.64"},{"date":"2024-09-30","value":"0.58","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.62 | 0.57 | 0.59 | 0.60 | 0.58 |
| 行业 | 2.74 | 2.89 | 2.81 | 2.64 | 2.92 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 51/219 ， 4/219。
[{"date":"2025-09-30","value":"62.76","vol":"33.75"},{"date":"2025-06-30","value":"64.90","vol":"33.79"},{"date":"2025-03-31","value":"64.67","vol":"34.04"},{"date":"2024-12-31","value":"61.35","vol":"34.19"},{"date":"2024-09-30","value":"44.18","vol":"33.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
62.76 | 64.90 | 64.67 | 61.35 | 44.18 |
| 行业(%) | 33.75 | 33.79 | 34.04 | 34.19 | 33.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.31","vol":"0.94"},{"date":"2025-06-30","value":"3.83","vol":"0.88"},{"date":"2025-03-31","value":"3.69","vol":"1.46"},{"date":"2024-12-31","value":"2.77","vol":"0.84"},{"date":"2024-09-30","value":"1.04","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
3.31 | 3.83 | 3.69 | 2.77 | 1.04 |
| 行业(%) | 0.94 | 0.88 | 1.46 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"-0.91","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-1.19","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.25","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.42","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.91","blueLineValue":"0.36","type":"YC"}]